Definium Therapeutics, Inc.
DFTXNasdaqCIK 1813814HealthcareFiscal year ends Dec 31
Reports and events: 150 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-03-1108:32 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-064380 |
| 2024-03-0708:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-061522 |
| 2024-03-0706:56 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-061361 |
| 2024-02-2807:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021656 |
| 2024-02-2807:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021650 |
| 2024-01-0808:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002705 |
| 2023-12-1407:57 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-294936 |
| 2023-11-0216:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058248 |
| 2023-11-0216:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-058230 |
| 2023-09-1517:27 ET | 8-K/A | 8.01 Other events | 0000950170-23-048432 |
| 2023-09-1517:23 ET | 8-K/A | 8.01 Other events | 0000950170-23-048428 |
| 2023-08-1416:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-042472 |
| 2023-08-1408:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-23-042086 |
| 2023-08-0316:24 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-038057 |
| 2023-08-0316:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-038033 |
| 2023-07-2517:14 ET | 8-K/A | 5.07 Shareholder vote results | 0000950170-23-034489 |
| 2023-06-2717:15 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-030195 |
| 2023-06-2016:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-028954 |
| 2023-06-1617:06 ET | 8-K | 8.01 Other events | 0000950170-23-028678 |
| 2023-06-1516:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-028341 |
| 2023-05-2408:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-023764 |
| 2023-05-1716:15 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-022731 |
| 2023-05-0416:21 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-017907 |
| 2023-05-0416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-017860 |
| 2023-04-1816:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-105045 |
| 2023-04-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-104977 |
| 2023-04-1407:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-012792 |
| 2023-03-1307:01 ET | 8-K | 8.01 Other events | 0001193125-23-068454 |
| 2023-03-0916:24 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-007053 |
| 2023-03-0916:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-007042 |
| 2023-01-0916:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-004781 |
| 2022-11-1008:21 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024192 |
| 2022-11-1008:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-024182 |
| 2022-09-2916:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-254344 |
| 2022-09-1408:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-244278 |
| 2022-08-2616:45 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-231372 |
| 2022-08-1116:20 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016893 |
| 2022-08-1116:03 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-22-016842 |
| 2022-07-2107:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-198495 |
| 2022-06-3017:16 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-186293 |
| 2022-06-0216:06 ET | 8-K | 3.01 Delisting notice; 5.07 Shareholder vote results | 0001193125-22-166211 |
| 2022-05-2316:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-157512 |
| 2022-05-1908:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-154517 |
| 2022-05-1608:21 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009955 |
| 2022-05-1608:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-009953 |
| 2022-05-1107:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-146904 |
| 2022-04-2607:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-118866 |
| 2022-04-1817:00 ET | DEF 14A | Proxy statementPeriod 2022-06-01 | 0001193125-22-108118 |
| 2022-03-2817:11 ET | 8-K | 2.02 Results of operations; 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-22-004801 |
| 2022-03-2808:57 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-004724 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 13:55 ET. Listed shows no prices and gives no investment advice.